About Erlanger Atopie Score
Instructions
Access Erlanger Atopie Score
Features
Our tools
Our Partners
English
Deutsch

Home

What is the Erlanger Atopie Score?

The Erlanger Atopy Score (Erlanger Atopie Score; EAS) was developed by Diepgen and colleagues in 1991 to determine atopic skin diathesis, i.e. the tendency of the skin to develop atopic eczema. This is a major risk factor for the occurrence of occupational skin diseases. The score is a systematically developed listing of anamnestic and clinical features to objectify the likelihood of atopic skin diathesis and the associated risk of eczema. The EAS was developed for, and should only be completed by, healthcare professionals.

How is the Erlanger Atopie Score structured?

The Erlanger Atopie Score consists of 24 criteria divided into 6 domains: atopic family history, atopic self history, atopic minimal forms, atopic stigmata, dermal neurovegetative and laboratory values. Each feature is scored based on relevance to atopic skin diathesis with a score of 0.5 - 3. The total score can range from 0 - 42. From 10 points, there is a likelihood of atopic skin diathesis, which is further substantiated from 15 points and 20 points. The EAS should only be completed by healthcare professionals.

When is the Erlanger Atopie Score used?

Persons with an atopic skin diathesis are exposed to an increased risk of developing hand eczema during occupational wet work (e.g. gardeners, cooks, geriatric nurses). The EAS can be used to detect these persons at an early stage, inform them about the risk, and recommend a retraining or a different choice of occupation. The use of the EAS is explicitly recommended in the "Bamberger Empfehlung - Empfehlung zur Begutachtung von arbeitsbedingten Hauterkrankungen und Hautkrebserkrankungen", of the German Social Accident Insurance.